|
Jun 25
|
Top Midday Decliners
|
|
Jun 25
|
Forte Biosciences Announces Pricing of $75 Million Public Offering
|
|
Aug 14
|
Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update
|
|
May 13
|
Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update
|
|
Mar 18
|
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
|
|
Dec 1
|
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
|